ProtonDx Company Research Report

Company Overview

• Name: ProtonDx Ltd

• Mission: No information is available

• Founded: 2020

• Founders: Dr. Jesus Rodriguez Manzano, Dr. Pantelis Georgiou, Dr. Nicolas Moser

• Key People:

• Bob Enck, CEO

• Dr. Jesus Rodriguez Manzano, CSO

• Pantelis Georgiou, Co-Founder & Director

• Ann Wong, CFO

• Headquarters: Imperial College, London

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: ProtonDx is known for its innovative diagnostic technologies and solutions, including the Dragonfly Molecular Diagnostic Platform that provides portable, rapid, and accurate diagnostics, especially noted for its use in sporting events like the Olympics and the Tour de France.

Products

Dragonfly Molecular Diagnostic Platform

• Description: The Dragonfly is a portable, rapid, multi-pathogen molecular diagnostic platform.

• Key Features:

• Multi-pathogen differentiation allows testing for multiple viruses simultaneously from a single sample.

• Portable with no requirements for benchtop equipment.

• Speed: Results in less than 30 minutes.

• Parallel processing capability (12 samples in an hour).

• High accuracy with PCR standards of sensitivity and specificity.

• Easy-to-use sample preparation (less than five minutes).

• Supported by a companion app for guided workflow and data capture.

SmartLid Viral RNA/DNA Extraction Kit

• Description: A proprietary kit for rapid nucleic acid sample extraction.

• Key Features:

• Utilizes magnetic key and lid for efficient nucleic acid transfer.

• Total nucleic acid extraction in <10 minutes.

• Compatible with various fluids, including cell-free fluids and whole blood.

TurboBeads

• Description: Next-generation magnetic beads for diagnostics.

• Key Features:

• Pure metal core yielding high magnetic saturation.

• Fast collection speeds, suitable for large volume extractions.

• Stable covalent binding with unmatched chemical and biological stability.

Recent Developments

New Products and Features

• SmartLid Launch: In 2023, ProtonDx launched the SmartLid Viral RNA/DNA Extraction Kit.

• CE-IVD Mark Achievements:

• Dragonfly received CE-IVD Mark approval enabling its commercial use in the EU and the UK.

Strategic Partnerships

• ProtonDx and Katalyst: Strategic partnership announced in January 2023 for distribution of the Dragonfly diagnostic system.

Key Developments and Activities

• Leadership Changes: Bob Enck appointed as CEO in February 2024. Ann Wong joined as CFO in March 2023.

• Regulatory Influence: Dr. Kasia Szostak-Lipowicz addressed a UN panel on transformative digital diagnostic technologies in December 2023.

• Notable Uses:

• Dragonfly platform used in major sports events.

• Supported the UK Team during the Tour de France 2023.

• Recognition: Dr. Jesus Rodriguez Manzano promoted to Associate Professor at Imperial College London in October 2023.

Research and Grants

• Porcine Grant Secured: £365,000 grant received to develop rapid tests for porcine lung diseases.

• AMR Focus: Dedicated efforts towards addressing antimicrobial resistance through better diagnostics.

Conclusion

ProtonDx has solidified its position in the diagnostics market through its innovative products like the Dragonfly Molecular Diagnostic Platform and strategic partnerships. The company continues to leverage its bespoke solutions to address various sectors in human health, animal health, and life sciences.